Sale!

TPI1 Gene Triosephosphate Isomerase Deficiency Genetic Test

Original price was: $700.Current price is: $500.

-29%

The TPI1 Gene Triosephosphate Isomerase Deficiency NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the TPI1 gene responsible for triosephosphate isomerase deficiency, a rare inherited metabolic disorder. This advanced next-generation sequencing test provides precise detection of genetic variants that disrupt glycolysis, leading to hemolytic anemia, neuromuscular dysfunction, and increased infection susceptibility. For individuals experiencing unexplained hemolytic anemia, neurological symptoms, or with family history of metabolic disorders, this $500 USD test offers crucial diagnostic clarity. Results guide personalized treatment strategies and inform family planning decisions through detailed genetic counseling.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

TPI1 Gene Triosephosphate Isomerase Deficiency NGS Genetic DNA Test

Comprehensive Genetic Analysis for Metabolic Health

The TPI1 Gene Triosephosphate Isomerase Deficiency NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying inherited metabolic disorders affecting cellular energy production. This specialized genetic examination utilizes next-generation sequencing technology to detect mutations in the TPI1 gene, which encodes the triosephosphate isomerase enzyme essential for proper glycolysis function.

What This Advanced Genetic Test Detects

Our comprehensive NGS-based analysis specifically targets the TPI1 gene located on chromosome 12p13, examining all coding regions and splice sites for pathogenic variants. The test identifies:

  • Point mutations affecting enzyme structure and function
  • Frameshift mutations disrupting protein synthesis
  • Nonsense mutations leading to premature termination
  • Splice site variants affecting mRNA processing
  • Missense mutations altering catalytic activity

Who Should Consider TPI1 Genetic Testing?

This specialized genetic test is recommended for individuals presenting with clinical features suggestive of triosephosphate isomerase deficiency or those with concerning family history patterns.

Clinical Indications and Symptoms

  • Unexplained chronic hemolytic anemia unresponsive to conventional treatments
  • Progressive neuromuscular dysfunction including muscle weakness and spasticity
  • Recurrent infections and immune system abnormalities
  • Developmental delays in childhood with neurological deterioration
  • Family history of metabolic disorders or consanguineous relationships
  • Unexplained neonatal jaundice or hemolytic crises

Significant Benefits of Genetic Testing

Undergoing TPI1 genetic testing provides numerous advantages for patients and healthcare providers:

Diagnostic Clarity and Precision

  • Definitive molecular diagnosis eliminating diagnostic uncertainty
  • Accurate differentiation from other hemolytic anemias and metabolic disorders
  • Comprehensive genetic characterization guiding personalized treatment approaches

Family Planning and Genetic Counseling

  • Informed reproductive decision-making through carrier testing
  • Prenatal diagnosis options for at-risk pregnancies
  • Identification of asymptomatic carriers within families

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your TPI1 gene status with expert interpretation:

Result Interpretation Guidelines

  • Positive Result: Identification of pathogenic variants confirms triosephosphate isomerase deficiency diagnosis, enabling targeted management strategies
  • Negative Result: No disease-causing mutations detected, significantly reducing likelihood of TPI deficiency
  • Variant of Uncertain Significance: Identification of genetic changes requiring additional family studies for clinical interpretation
  • Carrier Status: Identification of single pathogenic variant indicating carrier state with implications for family members

Test Pricing and Specifications

Test Feature Details
Test Name TPI1 Gene Triosephosphate Isomerase Deficiency NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Methodology Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements and Preparation

To ensure optimal testing outcomes, we recommend the following preparatory steps:

Essential Pre-Test Documentation

  • Complete clinical history detailing symptoms, previous treatments, and family medical background
  • Genetic counseling session to construct comprehensive pedigree chart documenting affected family members
  • Informed consent discussion covering test implications, limitations, and potential outcomes

Nationwide Accessibility and Convenience

General Genetics Corporation maintains comprehensive testing facilities across the United States, ensuring convenient access to advanced genetic diagnostics. Our network includes specialized centers in:

Major Metropolitan Locations

  • New York City metropolitan area with multiple collection sites
  • Los Angeles and Southern California regional centers
  • Chicago and Midwest genetic testing facilities
  • Houston and Texas-based diagnostic laboratories
  • Phoenix and Southwest genetic medicine centers
  • Additional locations serving all major urban centers nationwide

Take Control of Your Genetic Health Today

Don’t let diagnostic uncertainty compromise your health management. Our TPI1 Gene Triosephosphate Isomerase Deficiency NGS Genetic DNA Test provides the definitive answers you need for informed medical decisions and personalized treatment planning.

Schedule your comprehensive genetic assessment today by calling our dedicated genetics specialists at +1(267) 388-9828 or book your appointment online through our secure patient portal.

Experience the confidence that comes with precise genetic diagnosis and expert-guided interpretation from America’s leading metabolic genetics testing provider.